Our research projects include evaluating ways to improve osteoporosis diagnosis, investigating the role of nutrition in osteoporosis development and prevention, and evaluating new medications to prevent or treat osteoporosis and bone disease.

• Diagnosis:
  A goal of the Research Program is to help improve how osteoporosis is diagnosed clinically. We have conducted several studies on osteoporosis diagnosis and have identified conditions that may interfere with measurement accuracy. Additionally, we collaborate with manufacturers to evaluate new instruments and techniques.
  
  
• Nutrition:
  Inadequate nutrition contributes to bone loss and osteoporotic fracture. Prior research has established the important roles of calcium and vitamin D. However, it is likely that other dietary factors contribute to bone loss; we are interested in identifying how inadequate or excessive intake of other nutrients may effect bone health.
  
  
• Prevention:
  Menopause is associated with rapid bone loss in most women. Additionally, certain medications or treatments cause bone loss. Since these events can be easily identified, there are logical times when efforts to prevent osteoporosis can be implemented. As such, we are investigating new approaches to help prevent the development of osteoporosis.
  
  
• Treatment:
  The UW Osteoporosis Research Program conducts clinical studies that examine new and exitsting osteoporosis treatments. These studies may provide additional information about, or improve upon, currently available medications.

The following is a list of current research studies being
conducted at the UW Osteoporosis Research Program

RAPID ONSET

Eligibility criteria:

• Women 65 years of age or older
• Have, or concerned that you may have, osteoporosis
• Are not on treatment medication for osteoporosis

RHEUMATOID ARTHRITIS AND VITAMIN D STUDY

This is a one-year clinical research study investigating the role of vitamin D supplementation in individuals with rheumatoid arthritis.

Eligibility criteria:

• Men or women,18 years or older, with a diagnosis of rheumatoid arthritis